Answers are grounded in this paper and cite their sources.
Most diseases are not caused by large-effect single factors but by the cumulative impact of small, context-dependent perturbations arising from genetic variants, personal behavior, or environmental exposures, a phenomenon we term the “long tail” of biology. Early disease signals often differ from late-stage biomarkers and evolve across demographic, lifestyle, and environmental contexts. Shifting medicine from reactive treatment to proactive health requires detecting and interpreting these signals. This requires longitudinal, multimodal data collection; non-invasive, scalable biosensing platforms; new technologies for interrogating biological complexity; and AI models capable of contextual, mechanistic reasoning. We propose an “N-of-1 analyzer” framework to track divergence from personal baselines across analytes, relationships, networks, and trajectories, interpreted through digital-twin simulations and knowledge-grounded foundational models. This framework enables early, individualized insights into disease risk and system decline, offering a path toward scalable precision prevention. Regulatory innovations will have to evolve, embracing complexity instead of reducing it to the mean.
No takes yet. Share an insight, caveat, or question.
Rappaport et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: